文献速递脑血管病

基底动脉闭塞的病因特异性血管内取栓时间窗:ATTENTION试验事后分析

Cause-Specific Endovascular Thrombectomy Time Windows in Basilar Artery Occlusion: ATTENTION Trial Post Hoc Analysis
RSS 订阅 · Stroke

该研究基于ATTENTION试验340例基底动脉闭塞患者,按发病至穿刺时间(<6小时 vs ≥6小时)和TOAST病因分层,探讨病因对血管内取栓时间敏感性的影响。结果显示非动脉粥样硬化性BAO在<6小时取栓获益显著(46.7% vs 20.4%,RR 2.29,P=0.007),而动脉粥样硬化性BAO在≥6小时仍有数值获益且改良Rankin量表有序分析显著(cOR 3.30,P=0.029)。治疗时间×病因交互作用不显著(P=0.662),结论为假设生成性。

要点

  • 非动脉粥样硬化性BAO在发病至穿刺<6小时取栓获益显著,≥6小时获益丧失显著性。
  • 动脉粥样硬化性BAO在≥6小时取栓仍有数值获益,且改良Rankin量表有序分析显著。
  • 治疗时间与病因的交互作用不显著(P=0.662),结果需前瞻性验证。

核心结论

  • 动脉粥样硬化性基底动脉闭塞对取栓时间敏感性较低,可能在延长时间窗内仍保持取栓反应性。

研究设计与样本

  • ATTENTION试验事后分析,纳入36家中国中心2021–2022年随机数据,共340例患者(226例取栓+药物治疗,114例单纯药物治疗)。
  • 按发病至穿刺时间(<6小时 vs ≥6小时)和TOAST病因(动脉粥样硬化性 vs 非动脉粥样硬化性)分层。

主要发现

  • 发病至穿刺<6小时,非动脉粥样硬化性患者取栓组90天良好功能结局率46.7% vs 20.4%(RR 2.29,95%CI 1.25–4.18,P=0.007)。
  • 发病至穿刺<6小时,动脉粥样硬化性患者取栓组良好结局率40.4% vs 26.1%(P=0.259)。
  • 发病至穿刺≥6小时,动脉粥样硬化性患者取栓组良好结局率56.9% vs 26.3%(P=0.199),改良Rankin量表有序分析cOR 3.30(95%CI 1.13–9.62,P=0.029)。
  • 发病至穿刺≥6小时,非动脉粥样硬化性患者取栓组良好结局率39.5% vs 21.7%(P=0.341)。
  • 治疗时间×病因交互作用P=0.662;加权1小时间隔比值比趋势分析提示非动脉粥样硬化性患者暂定5.3小时参考点。

临床怎么用

  • 非动脉粥样硬化性基底动脉闭塞应尽早行血管内取栓,不宜延迟。
  • 动脉粥样硬化性基底动脉闭塞在超过6小时时间窗内仍可考虑取栓,但需个体化评估。

局限性

  • 本研究为事后分析,结果属假设生成性,需前瞻性研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Stroke, Ahead of Print. BACKGROUND:Endovascular thrombectomy (EVT) outperforms best medical treatment (BMT) for basilar artery occlusion (BAO), but the influence of stroke cause on the time sensitivity of EVT remains unclear. We hypothesized nonatherosclerotic BAO would require earlier EVT, whereas atherosclerotic BAO—with chronic stenosis and more robust collaterals—would retain EVT benefit in extended windows. We conducted a post hoc 3-way interaction analysis of the ATTENTION trial (Trial of Endovascular Treatment of Acute Basilar Artery Occlusion) to explore cause-specific EVT time patterns.METHODS:Using randomized ATTENTION trial data (36 Chinese centers, 2021–2022), patients were stratified by onset-to-puncture time (<6 versus ≥6 hours) and TOAST (Trial of ORG 10172 in Acute Stroke Treatment) cause (atherosclerotic: large-artery atherosclerosis; nonatherosclerotic: cardioembolism/undetermined/other causes). The primary outcome was 90-day favorable functional outcome (modified Rankin Scale score 0–3), with relative risk as the primary estimand; the 3-way interaction was tested via joint Wald test. A weighted 1-hour interval odds ratio trend analysis served as an exploratory tool, with multivariable regression adjusting for confounders.RESULTS:Among 340 patients (226 EVT+BMT, 114 BMT), for onset-to-puncture time <6 hours, patients without atherosclerosis with EVT achieved a significantly higher favorable outcome rate (46.7% versus 20.4%; relative risk, 2.29 [95% CI, 1.25–4.18];P=0.007); patients with atherosclerosis showed numerical outcome benefit (40.4% versus 26.1%,P=0.259). For onset-to-puncture time ≥6 hours, numerical benefit of patients with atherosclerosis increased from 14.3% to 30.6% (56.9% versus 26.3%;P=0.199), accompanied by ordinal modified Rankin Scale score improvement (common odds ratio, 3.30 [95% CI, 1.13–9.62];P=0.029) and National Institutes of Health Stroke Scale score reduction; patients without atherosclerosis’ benefit decreased from 26.3% to 17.8% with loss of significance (39.5% versus 21.7%,P=0.341). The treatment time×cause interaction was not significant (P=0.662). The weighted 1-hour interval odds ratio trend analysis identified a provisional 5.3-hour reference point in patients without atherosclerosis.CONCLUSIONS:Compared with nonatherosclerotic BAO, atherosclerotic BAO appears less time-sensitive, potentially retaining EVT responsiveness over longer windows. These findings are hypothesis-generating and require prospective

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Stroke:Cause-Specific Endovascular Thrombectomy Time Windows in Basilar Artery Occlusion: ATTENTION Trial Post Hoc Analysis

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。